Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Financial Officer | Nov 17, 2022 | |||
LEXX, LEXXW | Lexaria Bioscience Corp. | Chief Executive Officer | Aug 31, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|